Background and Objective: Persistent ulcers in patients with diabetic foot syndrome in 85% of cases lead to amputation because of secondary infection and growing gangrene that significantly worsen the prognosis. Methods: It was found, that in patients with diabetic foot infection dominated Gram-positive microorganisms (62.7%). It was detected Staphylococcus aureus (23.4%), Staphylococcus spp. (25.8%), and Enterococcus spp. (14.5%). Among the Gram-negative aerobes, Pseudomonas spp. was the more frequently isolate (14.5%). Enterobacteriaceae were detected in 18.5% cases. Candida spp. was isolated in 1.6% cases. It was dominated Gram-positive cocci in Wagner Grade I-III: S. aureus was isolated in 36.34% -23.89% cases; Staphylococcus spp. was detected in 22.22% -28.94% cases; Enterococcus spp. was determined at 8.33% -18.5% cases in Wagner Grade IV and V was found increased amount Gram-negative rods from 39.18% tо 63.63%, respectively. It was presented Enterobacteriaceae spp. and Pseudomonas aeruginosa. Results: The analysis of antibiotic susceptibility of Gram-positive strains recorded increase of resistance to oxacillin in isolated strains of Staphylococcus spp. (S. aureus and coagulase-negative staphylococci) from 25% to 100% in Wagner Grade I and V, respectively. In Wagner Grade IV and V was detected Enterobacteriaceae producing extended spectrum beta lactamase in 75% (Escherichia coli, Klebsiella pneumoniae, and Citrobacter diversus) and 83.3% (E. coli, Proteus vulgaris, and K. pneumonia) cases, respectively. Studying the P. aeruginosa sensitivity to antibiotics in Wagner Grade IV and V was registered decrease susceptibility to ceftazidime in 36.36% and 0%, meropenem in 85.7% and 50%, levofloxacin in 68.18% and 50%, ciprofloxacin in 54.54% and 50%, and amikacin in 42.7% and 33.3%, respectively. Conclusion: It is discussed the approaches to the choice of starting antibacterial agents depend on the structure of pathogens and their sensitivity to antibiotics in patients with diabetic foot ulcers with different Wagner grades in patients with diabetic foot syndrome undergoing inpatient treatment in St. Joseph Belgorod Regional Clinical Hospital.
INTRODUCTION

D
iabetes mellitus (DM) is one of the most common high-cost chronic diseases and the most acute medical and social problem. Over the past decade, the world number of patients with DM has increased more than 2 times and reached 387 million people by the end of 2014. According to the prognosis of the International Diabetes Federation, nearly 592 million people will suffer from diabetes by 2035. [1] Pathogenesis of noninsulin dependent DM is insulin resistance, which is the cause of many metabolic disorders,
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including hyperglycemia, hypertriglyceridemia raising lowdensity lipoprotein, decrease in high-density lipoprotein, is activated by the process of lipid peroxidation, and hyperhomocysteinemia. As a result, of these changes is the development of endothelial dysfunction, which leads to the appearance of neuropathy and angiopathy. [2, 3] One of the late complications of DM is a diabetic foot syndrome, which includes a set of pathological changes on the foot and the lower limbs characterized by the development of diabetic foot ulcer, neuropathic osteoarthropathy, diabetic neuropathy, and inflammation or purulence complications in patients with DM. This requires optimization approaches to complex pharmacotherapy. [4] [5] [6] [7] [8] [9] [10] [11] [12] The aim of this study is the determination of antibiotic agents for the treatment patients with diabetic foot infections (DFI) on admission. Foot ulcer was graded according to Wagner's classification: Grade 0, high-risk foot; Grade I, superficial ulcer; Grade II, deep ulcer penetrating to tendon, bone, or joint; Grade III, deep ulcer with abscess or osteomyelitis; Grade IV, localized gangrene; and Grade V, extensive gangrene requiring a major amputation. [13] According to the type of diabetic foot syndrome, we revealed neuropathic and neuroischemic variants of the diabetic foot syndrome. The most common were neuropathic type of diabetic foot syndrome. It was determined in 58.6% of patients/neuroischemic type of diabetic foot syndrome was found in 41.4% of patients. [17] but exceeds the number of isolated strains according to data by Privolnev. [14] In patients with Grades II and III Gram-negative organisms were presented Enterobacteriaceae and Pseudomonas aeruginosa. Among Enterobacteriaceae, it was detected E. coli (11 The analysis of antibiotic susceptibility of Gram-positive strains recorded increase of resistance to oxacillin in isolated strains of S. aureus and coagulase-negative staphylococci in more severe tissue damage in patients with diabetic foot ulcer [ Figure 1 ]. It was shown the increase in the number of methicillin-resistant strains of S. aureus from 30.7% and 34.61% cases in Grade I and II, respectively, to 55.5% and 63.15% cases in Grade III, and IV, that is less than the level of resistance revealed by domestic authors in the period until 2011. [14] According to foreign authors, the level of S. aureus resistance to oxacillin ranged from 0% of resistant strains isolated from patients undergoing treatment of diabetic foot syndrome in the surgical department of Ouagadougou hospital (Burkina Faso) up to 100% resistance in strains isolated from patients, undergoing treatment at the central hospital in Mexico City (Table 1) . [18, 19] The same trend was observed among strains of coagulasenegative staphylococci. In patients with I and II Grade, it was allocated 25% and 30.4% methicillin-resistant strains, respectively, with Grade III and IV were verified 54.5% and 66.6% of strains resistant to oxacillin, respectively. All strains of S. aureus and Staphylococcus spp., which were isolated in V Grade, were methicillin-resistant.
Objectives of the Study
The analysis of antibiotic susceptibility of Enterococcus spp. was shown that all of the isolates were susceptible to ampicillin in Grade I and II. Susceptibility to ampicillin was retained in 50% cases and 66.6% cases in 3 and 4, respectively. In patients with Grade V, all strains Enterococcus spp. were resistant to ampicillin and at a detectable sensitivity to vancomycin.
All strains of Enterobacteriaceae were sensitivity to amoxicillin/ clavulanate, cephalosporins, carbapenems, fluoroquinolones, and amikacin in Grade I. All of registered Enterobacteriaceae strains were susceptible to amoxicillin/clavulanate, cephalosporins, carbapenems, fluoroquinolones, amikacin, except 2.63% strain of E. coli in Grade II, and 3.03% of strain E. coli in Grade III, which were produced beta-lactamase extended spectrum. We found these pathogens resistant to amoxicillin/clavulanate, cephalosporins. The strain of E. coli, isolated in Grade III was also resistant to ciprofloxacin and amikacin with preserved sensitivity to carbapenems.
In Grade IV was allocated 75% of strains of Enterobacteriaceae producing beta-lactamase extended spectrum: Strains of E. coli (3.22%), K. pneumonia (4.03%), and C. diversus (1.07%) found resistance amoxicillin/clavulanate, cephalosporins when the stored sensitivity to carbapenems. K. pneumonia and C. diversus, which were found, preserved susceptibility to fluoroquinolones, amikacin. In the analysis of the sensitivity of the selected strains of M. morganii registered its sensitivity to cephalosporins, carbapenems, and fluoroquinolones. In patients with Grade V feet on the degree of destruction Wagner Enterobacteriaceae accounted for 37.5% of the total allocation of pathogens, of which 83.3% of isolates produced beta-lactamase extended spectrum. All isolates of Enterobacteriaceae showed sensitivity to carbapenems and recorded resistance to fluoroquinolones. Sensitivity to aminoglycosides was differed in isolated Enterobacteriaceae. E. coli was characterized by resistance to amikacin; strains were K. pneumoniae susceptible to amikacin in 50% of cases, P. vulgaris in 100% of cases showed its sensitivity to amikacin.
Studying the P. aeruginosa sensitivity to antibiotics an increase in resistance level to β-lactams was registered at deep lesions. Thus, the resistance to cefepime reduced from 100% in Grade II to 50% in Grade V, at the same time there revealed a low sensitivity to ceftazidime, which was 60% in Grade II to 0% sensitive strains in V Grade. All isolated strains of P. aeruginosa were showed sensitivity to imipenem. Strains, which were isolated in IV and V Grade were resistant to meropenem in 85.7% and 50% cases, respectively.
We revealed a low sensitivity of P. aeruginosa to amikacin: From 33.3% tо 50% were susceptible to amikacin in patients with DFI. Sensitivity to gentamicin varied from 66.6% susceptible strains in Grade III tо 50% susceptible strains in Grade V. It was detected sensitivity to netilmicin, which ranged from 75% tо 100%. It was detected low sensitivity to fluoroquinolones: Susceptible strains P. aeruginosa to ciprofloxacin, which ranged from 75% tо 50%, in III-V Grade. We revealed a reduction in sensitivity to levofloxacin from 80% in Grade II tо 50% in Grade V. In comparison with the data by Privolnev 2011, there is an increase in P. aeruginosa resistance to cephalosporins, fluoroquinolones, and aminoglycosides, in contrast to, in particular, netilmicin and less amikacin and gentamicin revealed in the studied period. [14] The isolated strains of A. baumannii in Grade IV and had a high level of resistance to different groups of antibacterial drugs. The isolated strains are resistant to penicillins, cephalosporins, fluoroquinolones, and aminoglycosides. In 100% of cases, the microorganisms are sensitive only to the carbapenems ( Table 2 ). The researchers of Belgorod Regional Clinical Hospital revealed a higher level of resistance of A. baumannii as compared with the data of other researchers. In patients with Grade III-IV, recommends to use vancomycin, fluoroquinolones, and cefoperazone with further correction of antibiotic therapy based on bacteriological examination of data. In patients with Grade V recommends for Gram-positive flora must be allocated to the use of vancomycin, with Gramnegative flora is possible to use amikacin, with proven sensitivity cefoperazone, cefepime, and fluoroquinolones. Carbapenems, to use as antibacterial therapy for allocating allowance Enterobacteriaceae producing beta-lactamase spread spectrum. When Pseudomonas infection as therapy reserve can be used imipenem/cilastatin.
